1 40150sek
1,2 %
Date:2025-06-04Time:18:00:00Latest report:Q1-2025List:Large CapTicker:AZN
Market Cap:2 173 247 msekEnterprise Value:2 420 026 msekNet Sales:54 982 musdEarnings:7 772 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 401,50
MA50:1 367,26
MA200:1 511,40
Price/MA200:-7,3 %
RSI (14):58,9
Price/MA50:2,5 %

Description

AstraZeneca is a global biopharmaceutical company that focuses on the research, development, and marketing of prescription drugs, primarily for the treatment of diseases in the areas of therapy that affect the respiratory tract, cardiovascular / metabolism, and cancer. In addition to its main operations, the company is also active in autoimmunity, neuroscience, and infection. AstraZeneca is active in all global regions and is headquartered in Cambridge.

Pharmaceuticals